- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of PAWR predicts prognosis of ovarian cancer
Authors
Keywords
-
Journal
Cancer Cell International
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-14
DOI
10.1186/s12935-020-01704-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients
- (2020) János Tibor Fekete et al. GYNECOLOGIC ONCOLOGY
- Comprehensive analysis of the value of RAB family genes in prognosis of breast invasive carcinoma
- (2020) Shitong Lin et al. BIOSCIENCE REPORTS
- Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico
- (2020) Jingxuan Chen et al. Cancer Cell International
- Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer
- (2020) Fangfang Bi et al. Cancer Cell International
- PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
- (2020) Vera Loizzi et al. Oncology Letters
- DNA damaging agents in ovarian cancer
- (2020) Maria-Pilar Barretina-Ginesta EJC SUPPLEMENTS
- Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia
- (2018) Mary K. McKenna et al. BLOOD
- Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K–Akt Inhibition
- (2018) Jeffrey S. Damrauer et al. MOLECULAR CANCER RESEARCH
- C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation
- (2018) Dan Liu et al. Nature Communications
- Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
- (2018) Ádám Nagy et al. Scientific Reports
- Potential therapeutic agents against Par-4 target for cancer treatment: where are we going?
- (2018) Renata Virginia Cavalcanti Santos et al. CURRENT DRUG TARGETS
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- The Gene Ontology Resource: 20 years and still GOing strong
- (2018) NUCLEIC ACIDS RESEARCH
- Open Targets Platform: new developments and updates two years on
- (2018) Denise Carvalho-Silva et al. NUCLEIC ACIDS RESEARCH
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer
- (2017) Jim Moselhy et al. NEOPLASIA
- Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
- (2016) Mikkel Rosendahl et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells
- (2016) KAI YANG et al. ONCOLOGY REPORTS
- Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia
- (2015) Md Almamun et al. Epigenetics
- Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway Analysis
- (2015) Tong Wu et al. PLoS One
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer
- (2015) Yingying Zhou et al. Journal of Ovarian Research
- Atypical Protein Kinase C Zeta: Potential Player in Cell Survival and Cell Migration of Ovarian Cancer
- (2015) Kelly K. Y. Seto et al. PLoS One
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Secretory prostate apoptosis response (Par)-4 sensitizes multicellular spheroids (MCS) of glioblastoma multiforme cells to tamoxifen-induced cell death
- (2014) Jayashree C. Jagtap et al. FEBS Open Bio
- Promoter-targeted double-stranded small RNAs activate PAWR gene expression in human cancer cells
- (2013) Kai Yang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells
- (2013) MICHELLY C. PEREIRA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Par-4/THAP1 complex and Notch3 competitively regulated pre-mRNA splicing of CCAR1 and affected inversely the survival of T-cell acute lymphoblastic leukemia cells
- (2013) C Lu et al. ONCOGENE
- Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT
- (2013) Jiaxin Tan et al. TOXICOLOGY LETTERS
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Transcriptional regulation of pro-apoptotic Par-4 by NF-κB/p65 and its function in controlling cell kinetics during early events in endometrial tumourigenesis
- (2009) Makoto Saegusa et al. JOURNAL OF PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now